Hemoglobin Variants and Unstable Hemoglobin

Hemoglobin variants are structural forms of hemoglobin that arise from mutations altering the amino-acid sequence of a globin chain. Most are clinically silent, but some change the molecule's solubility, oxygen affinity, or stability. Unstable hemoglobins are a subset in which the altered chain precipitates within red cells, forming inclusions that shorten red-cell survival and can cause hemolytic anemia.

Definition

Hemoglobin variants are structurally abnormal hemoglobins produced by mutations in a globin gene that change the protein's amino-acid sequence; unstable hemoglobins are those variants whose altered structure causes them to denature and precipitate within the red cell, forming inclusions and reducing red-cell survival.

Scope

This topic surveys structural (qualitative) hemoglobin variants as a class, the consequences of altered solubility, oxygen affinity, and stability, and the distinction of unstable hemoglobins that precipitate to form inclusion bodies. Sickle cell disease, the most clinically important structural variant, is treated in its own entry and cross-linked here. This is a reference overview and does not provide individualized clinical guidance.

Core questions

• How can a single amino-acid change alter hemoglobin solubility, oxygen affinity, or stability?
• Why are most hemoglobin variants clinically silent while a few cause disease?
• What distinguishes an unstable hemoglobin from other structural variants?

Key concepts

• Structural (qualitative) hemoglobin variant
• Altered oxygen affinity (high- and low-affinity variants)
• Unstable hemoglobin and inclusion (Heinz) body formation
• Variant solubility and polymerization
• Hemoglobin electrophoresis and HPLC detection
• Clinically silent versus clinically significant variants
• Hb C and Hb E as common structural variants

Mechanisms

A mutation in a globin gene can substitute, delete, or extend amino acids in a globin chain, producing a structurally abnormal hemoglobin. The functional consequence depends on where the change falls. Substitutions at contact surfaces can shift the equilibrium between the high- and low-affinity states, producing variants that hold oxygen too tightly or release it too readily. Changes that affect solubility can promote crystallization or polymerization. Mutations that disrupt the folding of the globin chain or its binding to heme yield unstable hemoglobins: the chain denatures, precipitates as inclusion (Heinz) bodies attached to the red-cell membrane, and the affected cells are removed prematurely, producing a hemolytic anemia. Because many positions tolerate substitution without functional impact, most variants are clinically silent and discovered incidentally on hemoglobin analysis.

Clinical relevance

Hemoglobin variants are encountered routinely on hemoglobin electrophoresis and high-performance liquid chromatography, and distinguishing clinically silent variants from those that cause altered oxygen transport or hemolysis is part of interpreting these tests. This entry describes the class for reference and education and is not a basis for individual diagnosis or treatment.

Epidemiology

Hundreds of structural hemoglobin variants have been catalogued, but only a handful occur at appreciable population frequency. Hb C and Hb E, in particular, are common in West Africa and Southeast Asia respectively, where, like other hemoglobinopathy alleles, their frequency is attributed to malaria selection. Williams and Weatherall situate these variants within the broader, globally distributed burden of inherited hemoglobin disorders.

History

Following the recognition of sickle hemoglobin as a molecular disease, surveys of hemoglobin by electrophoresis revealed a growing catalogue of structural variants, many named for the place of discovery. Perutz's crystallographic work on hemoglobin structure provided the framework for understanding how specific substitutions alter oxygen binding and stability, and the systematic study of unstable hemoglobins clarified how denaturation and inclusion-body formation lead to hemolysis.

Key figures

• David Weatherall
• Thomas N. Williams
• Max Perutz
• Hermann Lehmann

Seminal works

• williams-weatherall-2012
• weatherall-2010

Frequently asked questions

Are all hemoglobin variants harmful?

No. Most structural hemoglobin variants are clinically silent and are found incidentally; only those that alter oxygen affinity, solubility, or stability tend to cause clinical effects.

What makes a hemoglobin 'unstable'?

An unstable hemoglobin carries a mutation that disrupts proper folding or heme binding, so the molecule denatures and precipitates inside the red cell as inclusion bodies, shortening the cell's survival and potentially causing hemolytic anemia.